See also this year's filing and all EDGAR filings for this company.
PDF Report 0001771917_2023_Karuna_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001771917, Karuna Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,154,769,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,201,000 |
| 3 | remainder_Assets | 5,364,000 |
| 4 | LiabilitiesCurrent | 33,946,000 |
| 5 | LiabilitiesNoncurrent | 3,150,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 76,066,000 |
| 9 | ResearchAndDevelopmentExpense | 224,247,000 |
| 10 | remainder_Expenses | 1,418,000 |
| 11 | remainder_Revenues | 10,637,000 |
| 12 | remainder_NetIncome | 14,758,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,793,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,163,334,000 |
| 1 | Liabilities | 37,096,000 |
| 2 | Expenses | 301,731,000 |
| 3 | Revenues | 10,637,000 |
| 4 | StockholdersEquity | 1,126,238,000 |
| 5 | NetIncome | -276,336,000 |
| 6 | ComprehensiveNetIncome | -277,732,500 |
| 7 | BaseVar | 765,174,500 |
| 8 | EconomicCapitalRatio | 2.76 |